Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec 10:12:815117.
doi: 10.3389/fphar.2021.815117. eCollection 2021.

Editorial: Therapeutic Drug Monitoring in Solid Organ Transplantation

Christine E Staatz  1 , Nicole M Isbel  2 , Troels K Bergmann  3   4 , Bente Jespersen  5 , Niels Henrik Buus  5
Affiliations
Editorial

Editorial: Therapeutic Drug Monitoring in Solid Organ Transplantation

Christine E Staatz et al. Front Pharmacol. .
No abstract available

Keywords: immunosuppressants; mycophenolic acid; personalizing therapy; solid organ transplantation; tacrolimus; therapeutic drug monitoring.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Therapeutic Drug Monitoring in Solid Organ Transplantation

References

    1. Bergan S., Brunet M., Hesselink D. A., Johnson-Davis K. L., Kunicki P. K., Lemaitre F., et al. (2021). Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther. Drug Monit. 43, 150–200. 10.1097/FTD.0000000000000871 - DOI - PubMed
    1. Brooks E., Tett S. E., Isbel N. M., McWhinney B., Staatz C. E. (2021). Evaluation of Bayesian Forecasting Methods for Prediction of Tacrolimus Exposure Using Samples Taken on Two Occasions in Adult Kidney Transplant Recipients. Ther. Drug Monit. 43, 238–246. 10.1097/FTD.0000000000000814 - DOI - PubMed
    1. Brunet M., van Gelder T., Åsberg A., Haufroid V., Hesselink D. A., Langman L., et al. (2019). Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Ther. Drug Monit. 41, 261–307. 10.1097/FTD.0000000000000640 - DOI - PubMed
    1. Scuderi C. E., Parker S. L., Jacks M., John G., McWhinney B., Ungerer J., et al. (2020). Kidney Transplant Recipient’s Perceptions of Blood Testing Through Microsampling and Venepuncture. Bioanalysis 12, 873–881. 10.4155/bio-2020-0057 - DOI - PubMed
    1. Shipkova M., Hesselink D. A., Holt D. W., Billaud E. M., van Gelder T., Kunicki P. K., et al. (2016). Therapeutic Drug Monitoring of Everolimus: A Consensus Report. Ther. Drug Monit. 38, 143–169. 10.1097/FTD.0000000000000260 - DOI - PubMed

Publication types

LinkOut - more resources